PATHFINDER Point-of-care Lab-on-Chip Detection of Host Response in Febrile Illness for Diagnosis and Etiology Research
- Coordinator
- Imperial College of Science Technology and Medicine, United Kingdom
- Runs
- 1 October 2026 to 31 March 2030
- Status
- Running
- EU funding
- €2.8m
- Total cost
- €3.2m
- Partners
- 6 organisations in 4 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101248850
What the project is doing
In the project's own words, from its summary on CORDIS.
Diagnostics are the biggest gap in the cascade of care for priority infectious diseases in sub-Saharan Africa (SSA). Lack of accessible and affordable diagnostics contributes to poor health outcomes, drives antimicrobial resistance, and impedes timely responses to emerging epidemics. The transformative potential of point-of-care molecular host response diagnostics has been recognised but until now, none have been developed specifically for the needs of SSA.
We have developed a lab-on-chip platform to detect malaria, bacterial, viral, and TB infections (and co-infections) based on differences in their host gene-expression response. In this project we will take this platform beyond proof-of-concept, evaluating it in relevant clinical settings to determine the cause of febrile illness in 1000 children in Burkina Faso and Ghana. Through engagement of stakeholders across the translational pathway, we will also assess and optimise usability, impact on care pathways and public health, regulatory approval processes, local manufacturing, and sustainable funding and access models.
In parallel we will build capacity in diagnostics research and innovation and train a cohort of future leaders in the field. This PATHFINDER project will provide evidence for a disruptive approach, with potential to transform the diagnostic ecosystem, and have wide-reaching impact on healthcare delivery in SSA.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Imperial College of Science Technology and Medicine | London | United Kingdom | Coordinator |
| Centre National De Recherche Scientifique Et Technologique*institut De Recherche En Sciences De La Sante | Ouagadougou | Burkina Faso | Participant |
| University of Ghana | Accra | Ghana | Participant |
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Participant |
| London School of Hygiene and Tropical Medicine Royal Charter | London | United Kingdom | Participant |
| ProtonDx Ltd | London | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI